Trial Profile
NEP-TUNE: Neuropathic Pain - Treatment With Pregabalin Under Real-life Conditions in Denmark.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Jan 2021
Price :
$35
*
At a glance
- Drugs Pregabalin (Primary)
- Indications Neuropathic pain
- Focus Therapeutic Use
- Acronyms NEP-TUNE
- Sponsors Pfizer
- 15 May 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 07 Oct 2013 Planned End Date changed from 1 Sep 2013 to 1 Apr 2014 as reported by ClinicalTrials.gov.
- 10 Sep 2013 Planned End Date changed from 1 Aug 2013 to 1 Sep 2013 as reported by ClinicalTrials.gov.